<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:dc="http://purl.org">
<channel>
<title>Daily Pharmaceuticals industry news in South Africa</title>
<link>https://www.bizcommunity.com/196/398.html</link>
<description>South Africa Pharmaceuticals news</description>
<ttl>15</ttl>
<category>Pharmaceuticals news - South Africa</category>
<image>
<url>https://www.bizcommunity.com/res/img/logo.gif</url>
<title>Daily Pharmaceuticals industry news in South Africa</title>
<link>https://www.bizcommunity.com/196/398.html</link>
</image>
<language>en-us</language>
<pubDate>Sun, 22 Nov 2026 01:01:59 +0200</pubDate>
<item>
	<title>A fresh dose: How South Africa’s paediatric syrup brands are refreshing their ranges</title>
	<link>https://www.bizcommunity.com/article/a-fresh-dose-how-south-africas-paediatric-syrup-brands-are-refreshing-their-ranges-851563a</link>
	<description>South Africa’s Paediatric Health market is seeing renewed activity in children's syrup products, as manufacturers update their offerings through reformulated ingredients, new flavours, expanded age-specific ranges and alternative packaging. While syrups remain an established format for children's medicines and nutritional supplements, recent developments from local market players show how brands are adapting their products to address different health needs and improve convenience for parents and caregivers.</description>
	<media:content url="https://biz-file.com/c/2611/827828.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2611/827828.jpg?5" length="84587" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2611/827828.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-273349</guid>
	<pubDate>Fri, 13 Nov 2026 13:54:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Aspen gets go-ahead to produce generic Ozempic and Wegovy</title>
	<link>https://www.bizcommunity.com/article/aspen-gets-go-ahead-to-produce-generic-ozempic-and-wegovy-417039a</link>
	<description>South African pharmaceutical company Aspen Pharmacare said it had received regulatory approval in Brazil and South Africa for its generic injectable semaglutide, paving the way for launches in two key emerging markets.</description>
	<media:content url="https://biz-file.com/c/2611/827567-1200x800.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2611/827567-1200x800.jpg?5" length="274577" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2611/827567.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-273275</guid>
	<pubDate>Wed, 11 Nov 2026 11:54:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Nationwide drug shortages raise concerns among SA psychiatrists</title>
	<link>https://www.bizcommunity.com/article/nationwide-drug-shortages-raise-concerns-among-sa-psychiatrists-639651a</link>
	<description>The South African Society of Psychiatrists (SASOP) is calling on Health Minister Aaron Motsoaledi to investigate reports of nationwide drug shortages. These shortages are affecting the treatment of mental illnesses, including schizophrenia, bipolar disorder and major depressive disorder.</description>
	<media:content url="https://biz-file.com/c/2611/827218-1200x800.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2611/827218-1200x800.jpg?5" length="360393" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2611/827218.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-273171</guid>
	<pubDate>Mon, 09 Nov 2026 10:03:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Aspen strikes R3.66bn deal for its menopause treatment</title>
	<link>https://www.bizcommunity.com/article/aspen-strikes-r366bn-deal-for-its-menopause-treatment-740042a</link>
	<description>Aspen Pharmacare announced it will sell the European commercialisation rights and related intellectual property for its women’s health product, Ovestin, to Ennogen Healthcare International for $220m (approximately R3.66bn at the current exchange rate of R16.62 per US Dollar).</description>
	<media:content url="https://biz-file.com/c/2611/826823-1200x802.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2611/826823-1200x802.jpg?5" length="296154" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2611/826823.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-273052</guid>
	<pubDate>Tue, 03 Nov 2026 07:44:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Good bacteria, broader choice: SA probiotics brands are differentiating their offerings</title>
	<link>https://www.bizcommunity.com/article/good-bacteria-broader-choice-sa-probiotics-brands-are-differentiating-their-offerings-073325a</link>
	<description>South Africa’s probiotic supplements market is growing as manufacturers develop products for different health needs and life stages. Alongside traditional capsules, consumers can now find drops, chewables, sprays and other formats, while brands are investing in education and clearer product information to help shoppers navigate their options.</description>
	<media:content url="https://biz-file.com/c/2611/826768.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2611/826768.jpg?5" length="109317" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2611/826768.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-273037</guid>
	<pubDate>Mon, 02 Nov 2026 15:15:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Dis-Chem brings the World of Beauty to Cape Town</title>
	<link>https://www.bizcommunity.com/article/dis-chem-brings-the-world-of-beauty-to-cape-town-858663a</link>
	<description>Canal Walk’s centre court buzzed with excitement as Dis-Chem officially opened the third edition of its World of Beauty in Cape Town — which ran until 1 November 2026.</description>
	<media:content url="https://biz-file.com/c/2610/826649-1200x839.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2610/826649-1200x839.jpg?5" length="442858" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2610/826649.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-272949</guid>
	<pubDate>Fri, 30 Oct 2026 16:43:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Dis-Chem’s Better Rewards programme supports 8% revenue growth</title>
	<link>https://www.bizcommunity.com/article/dis-chems-better-rewards-programme-supports-8-revenue-growth-414299a</link>
	<description>Dis-Chem reported an 8% increase in Group revenue to R23bn for the six months ended 31 August 2026, although earnings came under pressure, with basic earnings per share (EPS) down 13.3% to 64.1 cents and headline earnings per share (HEPS) declining 12.8% to 64.3 cents.</description>
	<media:content url="https://biz-file.com/c/2610/826578.png?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2610/826578.png?5" length="66452" type="image/png" />
	<media:thumbnail url="https://biz-file.com/c/2610/826578.png?5" width="240" height="135" />
	<guid isPermaLink="false">1-272985</guid>
	<pubDate>Fri, 30 Oct 2026 10:30:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Cipla wins court fight over HIV pill tender</title>
	<link>https://www.bizcommunity.com/article/cipla-wins-court-fight-over-hiv-pill-tender-525790a</link>
	<description>A court has set aside the awards for the daily HIV pill in a R15.5-billion antiretroviral tender.

Two winning bidders are excluded because the licence for the factory they relied on had expired before bidding closed.

The health department has 120 days to redo the awards, while current suppliers will keep delivering in the meantime.</description>
	<media:content url="https://biz-file.com/c/2610/826028.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2610/826028.jpg?5" length="47700" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2610/826028.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-272806</guid>
	<pubDate>Fri, 23 Oct 2026 09:29:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Buying Ozempic on Instagram is a major red flag, warns Novo Nordisk</title>
	<link>https://www.bizcommunity.com/article/buying-ozempic-on-instagram-is-a-major-red-flag-warns-novo-nordisk-969334a</link>
	<description>Novo Nordisk’s vice president and general manager in South Africa, Sara Norcross, said that online spaces are increasingly blurring the line between visibility and legitimacy as social media influencers, online stores, and messaging apps sell illicit and unregulated weight-loss drugs. She recently participated in the Pharmaceutical Task Group (PTG) Media in Sandton.</description>
	<media:content url="https://biz-file.com/c/2610/825369-1200x800.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2610/825369-1200x800.jpg?5" length="194207" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2610/825369.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-272604</guid>
	<pubDate>Fri, 16 Oct 2026 08:56:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Demand for cheaper Ozempic options prompts compounding rule review</title>
	<link>https://www.bizcommunity.com/article/demand-for-cheaper-ozempic-options-prompts-compounding-rule-review-292717a</link>
	<description>South Africa is revising its rules on customising medicines, including sought-after GLP-1 treatments for diabetes and weight loss, health regulators said, warning pharmacies not to act as small-scale manufacturers.</description>
	<media:content url="https://biz-file.com/c/2610/825244-1200x800.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2610/825244-1200x800.jpg?5" length="213706" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2610/825244.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-272570</guid>
	<pubDate>Thu, 15 Oct 2026 08:06:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
</channel>
</rss>